Prevalence of peripheral arterial disease in type 2 diabetic patients in Nongkhai municipality
Keywords:
Peripheral arterial disease (PAD), Ankle-Brachial Index (ABI), type 2 DiabetesAbstract
Objectives : Type 2 diabetes is a major risk factor for peripheral arterial disease (PAD). Resulting in chronic ischemia causing many problems to the diabetic foot, such as chronic wounds, infection and may leading to major amputation of lower limb or death. The objective of this study was to determine the prevalence and risk factors associated with the occurrence of asymptomatic PAD in type 2 diabetic patients in Nongkhai municipality. Materials & Method : The study was designed as a prospective descriptive, cross-sectional study. Data collection of type 2 diabetic patients from all communities in Nongkhai municipality. All patients were examined at Nongkhai Hospital between 1st September – 31th October 2015. Ankle- Brachial Index (ABI) was measured and PAD was defined as an ABI less than 0.9. Results : Total of 313 individuals were assessed. 101 men (32.67%), average age was 64.14 years, average duration of diabetes was 9.66 years. Most common comorbidities were hypertension (66.45%) and dyslipidemia (64.22%) and 12.98% also smoking. The prevalence of asymptomatic PAD was 21.41% (95% CI = 16.99, 26.37) and the risk factors associated with statistically significant (p < 0.05) include coronary arterial disease (p = 0.025), cerebrovascular disease (p = 0.041) and smoking (p = 0.048). Conclusion : Prevalence of asymptomatic PAD in type 2 diabetic patients in Nongkhai Municipality was 21.41% (95% CI = 16.99, 26.37) with relation to coronary arterial disease (p = 0.025), cerebrovascular disease (p = 0.041) and smoking (p = 0.048) with statistical significance
References
Rutherford RB, Flanagan DP, Gupta SK. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg. 1986;4(1) :80-94.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-society consensus for the man agement of peripheral arterial disease (TASC II). J Vasc Surg 2007;45 Suppl S: S5-67.
Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141(6):421-431.
Munter P, Wildman PR, Reynolds K, Desalvo KB, Chen J, Fonseca V. Relationship between HbA1c level and peripheral arterial disease. Diabetes Care 2005;28(8) : 1981-1987.
Creager MA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003;108:1527-32.
Michael SC, Frank BP, Daniel GC. et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. J Vasc Surg 2015;
:2S-41S.
Fowkes FG, et al: Comparison of global esti mates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382:1329-1340.
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extermity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interverntions, Society for Vascular Medicine and Biology, Society of Interventional Raidology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American
Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47:1239-1312.
Jessadapattarakun S, Chadchavalpanichaya N. The Prevalence of Asymptomatic Peripheral Arterial Disease in Diabetic Patients at Siriraj Hospital. J Thai Rehabil Med 2016; 26(2):54-60.
สุธน พรธิสาร, ณัฏฐิณี จรัสเจริญวิทยา, ทิพาพร ธารวานิช. การศึกษา ความชุกของภาวะหลอดเลือดแดง ส่วนปลายแข็งและอุดตัน ในผู้ป่วย บาหวานชนิด ที่ 2 ในโรงพยาบาลธรรมศาสตร์เฉลิมพระเกียรติ. ธรรมศาสตร์เวชสาร. 2551; 8:32-9.
American Diabetes Association: Peripheral Arterial Disease in People With Diabetes. Diabetes Care 2003;26(12): 3333-41.
Michael CS, Keith DC, Rabih AC. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg 2016;64: e1-e21.
Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20(2) :384-92.
Henri Stoffers, Paul Rinkens, Arnold Kester, Victor Kaiser, Jander Knottnerus. The Preva lence of Asymptomatic and Unrecognized Peripheral Arterial Occlusive Disease. Int J Epidemiol 1996;25(2):282-90.
สมชาย ดุษฎีเวทกุล. ความชุกของโรคหลอดเลือดแดงส่วนปลายตีบในผู้ป่วยที่มีความเสี่ยงต่อการเกิด ภาวะโรคหัวใจและหลอดเลือด[อินเตอร์เน็ต]. กรุงเทพมหานคร : ศูนย์การแพทย์กาญจนาภิเษกมหาวิทยาลัยมหิดล;[เข้าถึงเมื่อ12 เมษายน 60]. เข้าถึงได้จาก: http://www.gj.mahidol.ac.th/tech/FileDownload/File/D150511183616.pdf
Victor Aboyans, Michael HC, Pierre A, Matthew AA, Mark AC et al. Measurement and Interpreta tion of the Ankle-Brachial Index Circulation. 2012; 126:2890-2909.
Stella S. Daskalopoulou, Mariasoosai P, Stavros K. Kakkos et al. Association Between Ankle – Brachial Index and Risk Factor Profile in Patients Newly Diagnosed With Intermittent Claudication. Circ J 2008; 72: 441 – 448.
Hirsch A, Criqui M, Treat-Jacobson D, Regensteiner J, Creager M, Olin J et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286(11):1317e1324.
Selvin E, Erlinger TP. Prevalence and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110(6):738-743.
Selvine E, Marinopoulos S, Berkenblit G, Ramit T, Brancati FL, Powe NR et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141(6):421-431.
Cole CW, Hill GB, Farzad E, Bouchard A, Moher D, Rody K, et al. Cigarette smoking and peripheral arterial occlusive disease. Surgery 1993;114:753-7.
Powell JT, Edwards RJ, Worrell PC, Franks PJ, Greenhalgh RM, Poulter NR. Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study. Atherosclerosis 1997;129:41-8.
Bhatt D, Steg P, Ohman E, Hirsch A, Ikeda Y, Mas J, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-9.
Dormandy JA, Murray GD. The fate of the claudicant-a prospective study of 1969 claudicants. Eur J Vasc Surg 1991;5(2): 131-133.
Kannel WB, Skinner JJ, Schwartz MJ, Shurtleff D. Intermittent claudication. Incidence in the Framingham Study. Circulation 1970;41(5):875-883.
Downloads
Published
How to Cite
Issue
Section
License
- บทความที่ได้รับการตีพิมพ์ถือเป็นลิขสิทธิ์ของ โรงพยาบาลนครพนม
- ข้อความหรือข้อคิดเห็นต่างๆ เป็นของผู้เขียนบทความนั้นๆ ไม่ใช่ความเห็นของกองบรรณาธิการ
